We found an estimated reduction of 17% in the primary composite endpoint at 12 to 24 months of follow-up but it did not reach statistical significance (RR 0.83, 95% CI 0.52–1.33, Figure 2 ).
← all excerpts
Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis.
1
—
—